Pennsylvania 2025-2026 Regular Session

Pennsylvania Senate Bill SB190

Introduced

1/29/25

Refer

1/29/25

Caption

Providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

Latest PA SB190 Activity

View All Events: PA 2025-2026 Regular Session SB190

Companion Bills

No companion bills found.

Previously Filed As

PA S895

To promote transparency and prevent price gouging of pharmaceutical drug prices

PA HB07179

An Act Concerning Pharmaceutical Marketing And Pharmaceuticals.

PA SB2104

PHARMACEUTICALS-SOCIAL MEDIA

PA SB0003

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

PA HB4544

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

PA SB0317

Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for. Creates new act.

PA LD675

An Act to Protect Consumers by Increasing Transparency and Accountability in the Pharmaceutical Industry

PA SB3134

Combating Counterfeit Pharmaceuticals Act of 2025

PA HB1060

Modern Authentication of Pharmaceuticals Act of 2025

PA SB1553

Authorizes incentives for producing certain critical materials and pharmaceuticals

Similar Bills

No similar bills found.